# Evaluating a New Sensor That Measures the Health of the Retina in Normally-sighted Subjects

> **NCT05509608** · EARLY_PHASE1 · ENROLLING_BY_INVITATION · sponsor: **RetMap, Inc** · enrollment: 90 (estimated)

## Conditions studied

- Electrode Site Reaction

## Interventions

- **DEVICE:** RM Electrode
- **DEVICE:** ERG Jet Electrode

## Key facts

- **NCT ID:** NCT05509608
- **Lead sponsor:** RetMap, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-03-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-11-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05509608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05509608, "Evaluating a New Sensor That Measures the Health of the Retina in Normally-sighted Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05509608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*